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The Impact of Malaria Control on Infant Mortality
in Kenya
vikram pathania
University of Sussex
I. Introduction
Malaria is a leading cause of childhood morbidity and mortality worldwide.
It is estimated to account for 732,000 deaths among children age 5 or less,
or about 8% of all such deaths; the share in Africa is 16% ðBlack et al.
2010Þ. The childhood burden of malaria also leaves a lasting adverse imprint
on lives and economies ðGallup and Sachs 2001; Sachs and Malaney 2002;
Bleakley 2010b; Lucas 2010Þ.
There has been a rapid escalation of malaria control efforts in recent years.
Funding committed by major global ﬁnanciers of malaria control has in-
creased more than ninefold from less than US$0.2 billion in 2004 to about
US$1.8 billion in 2009 ðWHO 2010Þ. The Global Fund to Fight AIDS,
Tuberculosis and Malaria ðhereafter, Global FundÞ has played a major role in
this funding surge. Since its inception in 2002, the Global Fund dramati-
cally increased funding levels for HIV/AIDS, TB, and malaria in the devel-
oping world. By 2009, the Global Fund had approved proposals worth US
$19.2 billion, of which grants for malaria control account for US$5.7 billion
ðGlobal Fund 2010Þ.
Kenya adopted a new national malaria strategy in 2001. The strategy em-
phasized the distribution of insecticide-treated bed nets ðITNsÞ, in line with
a large body of evidence that ITNs were effective in reducing malaria. In ad-
dition, it recommended selective indoor residual house spraying for epidemic
control, a switch to a more effective and prompt treatment of malaria, and
prophylactic treatment for pregnant women in endemic areas. Akin to the
rest of sub-Saharan Africa, funding for malaria control in Kenya jumped in
2002 and showed major growth by 2005. Figure 1 charts the growth in fund-
ing for malaria control in Kenya.1 The Global Fund, the Presidential Malaria
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Initiative, and bilateral donors provided most of the increase in funding. To-
Figure 1. Annual malaria control funding in Kenya, 2001–9. Source: Annex 3, World Malaria Report ðWHO
2010Þ.
460 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Etal funding committed to malaria control in Kenya in 2004–9 amounted to US
$236.4 million, 66% of which was provided by the Global Fund ðWHO
2010Þ. Cumulative disbursements ðactual monies transferred from the Global
Fund to the Kenyan governmentÞ rose from US$4.6 million in 2004 to US
$107 million in 2009.2 A program review in 2009 found moderate progress
in access to effective treatment, prophylaxis for pregnant women, and the use
of indoor residual spraying. But it showed a striking increase in the owner-
ship and usage of ITNs by Kenyan households. The proportion of children
under 5 who used ITNs rose from 5% in 2003 to 39% in 2007 and 47% by
2008–9. In the malarious regions, ownership had grown to be in excess of
70%, and the proportion of children protected by ITNs was about 60%.
In this article, I investigate the impact of this rapid intensiﬁcation of ma-
laria control in Kenya. In particular, I use the quasi-experimental variation in-
duced by preexisting geographical variation in malaria in Kenya coupled with
a sharp escalation of the campaign to map out the impact of malaria control
on infant mortality. I choose to study the impact in Kenya for two main rea-
sons. First, it has geographically distinct regions with widely varying risk of ma-
2 See http://www.theglobalfund.org/en/commitmentsdisbursements/, accessed on April 28, 2011.This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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laria. In particular, some regions have very high risk of malaria and would be
Pathania 461expected to beneﬁt greatly from enhanced malaria control activities, while other
regions have very low risk of malaria and can usefully serve as controls. Second,
there are two conveniently timed Demographic and Health Surveys ðDHS
2003 and DHS 2008–9; see CBS, MOH, and ORC Macro 2004; KNBS and
ICF Macro 2010, respectivelyÞ that permit estimation of trends in infant mor-
tality before and after the intensiﬁcation of malaria control. The latter survey
is recent enough to allow detection of early impact.
I deﬁne 2004–8 as the postintensiﬁcation ðhereafter, “post”Þ and 1993–
2003 as the preintensiﬁcation ðhereafter, “pre”Þ periods. I ﬁnd large and sig-
niﬁcant reductions in postneonatal mortality ðdeath in the ﬁrst 1–11 months
of lifeÞ in the post period in the malarious regions relative to the nonmalar-
ious ones. Importantly, the pattern of reduction in infant mortality is con-
sistent with a stylized fact about the burden of malaria in infancy: life-
threatening malaria during infancy usually occurs in the later part of the ﬁrst
year of life, with very young infants enjoying signiﬁcant clinical protection
that is apparently maternally derived. I do not ﬁnd evidence for similar pre-
existing differential trends in infant mortality before the post period; the
estimate is robust to the inclusion of regional time trends. I also ﬁnd no ev-
idence of differential changes in maternal or infant care that could explain the
sharper reduction in mortality in the malarious regions. There was a boost in
funding for an HIV/AIDS program in the same period, but the ﬁndings are
robust to controlling for any contemporaneous impact of the HIV/AIDS
program on mortality. The preferred speciﬁcation suggests that the renewed
malaria campaign led to a fall of 33% in postneonatal mortality in malarious
regions that had a mean postneonatal mortality rate of about 75 per 1,000 in
the precampaign period.
This ﬁnding is consistent with those of several other studies based on ad-
missions and outcomes data from hospitals and health centers in various Afri-
can countries including Kenya. These studies have noted a dramatic reduction
in malaria case load and deaths in parallel with the intensiﬁed campaign against
malaria, while nonmalaria cases and deaths have remained stable or declined
only slowly ðOkiro et al. 2007; O’Meara et al. 2008; Otten et al. 2009; Snow
and Marsh 2010; Aregawi et al. 2011Þ.
This article adds to the existing literature on the efﬁcacy of ITNs. While
clinical trials have found that ITNs are effective against malaria, such trials
are characterized by high coverage and close monitoring. This article suggests
that ITNs have large health beneﬁts in the context of routine program im-
plementation with coverage rates of about 60% in malarious regions ðfor
children under 5 who sleep under ITNsÞ. The article also adds to the rapidlyThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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growing set of studies assessing the impact of the recent intensiﬁcation of ma-
462 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Elaria control. These studies tend to track changes in outcomes on the basis of
patient data from select health facilities. Use of nationally representative sur-
vey data such as the DHS allows for a more comprehensive and credible
mapping of malaria-related mortality trends as compared to data from health
center records and vital statistics registries, which usually have poor coverage
in developing country settings.
There has been a recent surge in the literature on the long-run beneﬁts of
historical malaria eradication campaigns ðBleakley 2010b; Cutler et al. 2010;
Lucas 2010Þ. This article extends this literature to the contemporary context:
the renewed campaign against malaria since the early 2000s. It also differs from
that literature in two important ways. First, it investigates the impact of con-
temporary malaria control that is centered on bed nets in contrast to earlier
malaria control efforts that were centered on DDT spraying. Second, I fo-
cus explicitly on the impact on mortality since the relevant parasite species
is Plasmodium falciparum, which causes more deadly malaria than Plasmo-
dium vivax, which is common in most of the settings in that literature. Credi-
ble and timely assessment of the extent of mortality and morbidity reductions
is critical for sustaining the recent momentum in malaria ﬁnancing and pro-
gram implementation.
II. Malaria in Kenya
Malaria is a leading cause of morbidity and mortality in Kenya. It accounts
for about 30%–50% of all outpatient visits and 20% of hospital admissions.
Pregnant women and children are particularly vulnerable; malaria is estimated
to account for about 20% of deaths among children under 5.3
There is wide geographical variation in the risk of malaria in Kenya.
Noor et al. ð2009Þ map the malaria risk across Kenya on the basis of Plasmo-
dium falciparum parasite rate ðPfPRÞ data assembled through cross-sectional
community-based surveys in 2,095 sites across the country from 1975 to 2009.
The PfPR is a commonly used measure of malaria risk in the population: it
is the proportion of the population that carries asexual blood stage parasites
ðSmith et al. 2007Þ. The mapping shows that over 86% of the Kenyan pop-
ulation resides in areas with very low malaria risk ðPfPR < 5%Þ. Only Nyanza
and the Western regions, both around Lake Victoria, have substantial risk of
malaria. In Nyanza, over 40%, and in the Western region, about 50%, of the
population resides in areas with a high risk of malaria ðPfPR > 40%Þ. In con-
3 Malaria Fact Sheet from the Malaria Control Program of Kenya; see http://www.nmcp.or.ke
/section.asp?ID54.
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trast, four other regions have a very low malaria risk. For instance, the PfPR
TABLE 1
MALARIA RISK PFPR IN KENYAN REGIONS
Distribution of Population by PfPR PfPR* HIV Ratey
<.1% .1%–1% 1%–5% 5%–10% 10%–20% 20%–40% >40% ð%Þ ð%Þ
Central 99.1 .9 .0 .0 .0 .0 .0 .055 7.6
Coast .3 28.2 68.0 .0 2.1 1.5 .0 2.96 6.6
Eastern 32.1 66.3 1.6 .0 .0 .0 .0 .429 6.2
Nairobi 100.0 .0 .0 .0 .0 .0 .0 .05 11.9
North Eastern 21.0 75.7 3.3 .0 .0 .0 .0 .526 0
Nyanza .0 7.9 39.9 .0 .2 11.2 40.8 33.19 18.3
Rift Valley 26.7 51.7 21.2 .0 .2 .1 .1 1.064 6.9
Western .0 .0 39.9 .0 .7 10.1 49.3 38.84 5.8
Sources. Montana, Neuman, and Mishra ð2007Þ and Noor et al. ð2009Þ, table 4.
* Regional PfPR ðPlasmodium falciparum parasite rateÞ calculated using the midpoints of the PfPR bands
and the share of population in band in columns 1–7. For the >40% band, the midpoint is assumed to be
70%.
y Among women age 15–49, based on Demographic and Health Survey 2003.
Pathania 463for the entire population of Nairobi is less than 0.1%. Table 1 shows the es-
timated distribution of regional populations by malaria risk. On the basis of
this distribution, I estimate the regional malaria risk by taking the weighted
average of the midpoints of the malaria risk bands—the weights being the
population share in each band.4 Figure 2 maps this regional distribution of ma-
laria risk.
A. Malaria Control in Kenya
By the late 1990s, there was a considerable body of evidence that the use of
ITNs reduced childhood mortality in sub-Saharan Africa ðsee Lengeler ½2004
for a review of several randomized controlled trials of ITNsÞ. In 2001 Kenya
adopted the National Malaria Strategy, 2001–2010 to combat malaria over the
coming decade ðDivision of Malaria Control 2001Þ; the strategy emphasized
the increased use of ITNs. Before 2001, access to nets was limited to sales
through the retail sector and localized distribution by some research and non-
governmental initiatives. In 2002, PSI Kenya received support from the UKDe-
partment for International Development to market partially subsidized ITNs
across Kenya. This was the only major ITN distribution campaign between
2002 and 2004, and it operated through the retail sector. The nets were priced at
US$4.70 in urban areas and at US$1.30 in rural areas. Starting in 2004, there
were more ambitious campaigns to increase coverage by distributing heavily
4 Since the >40% band is wide. I have checked the robustness of the ﬁndings to different assumptions
about the rate in that band. The results can be accessed in the online appendix; the estimates are
unchanged if I assume 60% or 80% instead of the 70% midpoint in the band.
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subsidized or free ITNs through multiple channels. PSI expanded its program
Figure 2. Regional distribution of Plasmodium falciparummalaria prevalence in Kenya. Source: Noor et al.
ð2009Þ, table 4.
464 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Eby distributing heavily subsidized ITNs throughmaternal and child health clin-
ics; these nets came bundled with insecticide retreatment tablets. These ITNs
were branded with the Ministry of Health logo and priced at merely US$0.70.
In 2004, Kenya also received a Global Fund grant to distribute 5 million long-
lasting insecticide nets free of charge to children under 5 years of age. While
regular ITNs are usually effective for about a year and a half, the long-lasting
versions have a life span of between 3 and 5 years. The distribution took
place in two phases in 2006 through health care facilities and mass vacci-
nation campaign points ðNoor et al. 2007Þ. From 2002 to 2008, an estimatedThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
All use subject to JSTOR Terms and Conditions
16 million bed nets were distributed through various channels ðKNBS and
Pathania 465ICF Macro 2010Þ.
Other major program components include vector control through indoor
spraying of houses, prophylactic treatment for all pregnant women, and more
prompt and effective treatment of malaria. The National Malaria Strategy rec-
ommended selective use of indoor residual spraying ðIRSÞ in the early detec-
tion phase of epidemics in the highlands and arid areas. The strategy also aimed
to deliver intermittent presumptive treatment in the second and third tri-
mesters to all pregnant women residing in endemic areas as part of routine an-
tenatal care. For case management, the target was to deliver malaria treatment to
60% of all fever cases within 24 hours of the onset of fever. In response to
growing drug resistance, in 2006 Kenya switched its ﬁrst-line treatment pro-
tocol for treating uncomplicated cases of malaria. Instead of being treated with
sulfadoxine-pyremethamine, malaria cases were now to treated with the more
effective artemisinin-based combination therapy that works well against drug-
resistant strains.
Figure 3 illustrates the nationwide progress of the malaria control cam-
paign. It is based on a detailed performance review of the malaria program in
2009 ðDivision of Malaria Control 2009Þ. There has been only a modest in-
crease in access to effective treatment and in the provision of intermittentFigure 3. Performance of Kenya Malaria Control Program. Source: Kenya Malaria Program Performance
Review ðDivision of Malaria Control 2009Þ.
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presumptive treatment to pregnant women. Access to prompt and effective
treatment by artemisinin-based combination therapy has grown slowly due to a
466 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Enumber of reasons. There have been frequent drug stock outs due to persistent
distribution bottlenecks. Further, much of malaria treatment takes place in the
informal sector, and many nonrecommended drugs including substandard
antimalarial medicines can be purchased easily over the counter ðChuma et al.
2009Þ. The provision of prophylaxis during pregnancy has been hampered by
late presentation of pregnant women for antenatal care, drug stock outs, and a
shortage of trained health workers.
The performance review also found that IRS had been implemented an-
nually in epidemic-prone areas since 2005 with support from various donors.
IRS campaigns were supported by the British Department for International
Development in 2005–9, the Global Fund in 2006–9, and the President’s Ma-
laria Initiative in 2007–9. The intensity of IRS campaigns appears to have
ﬂuctuated, driven in part by an inconsistent ﬂow of ﬁnancing. For instance,
in 2008, 63% of the targeted houses were sprayed, which afforded protection
to about 3.1 million people. But in 2009, only 33% of the target was reached
due to delays in donor fund disbursement. Other performance issues are re-
lated to lack of proper maps of areas for IRS spraying and poor quality control
of pumps and insecticides. In Kenya, the areas west of the Rift Valley and arid
and semiarid zones are prone to occasional malaria epidemics. In the current
analysis, these areas are included in the nonmalarious regions. To the extent
that the IRS campaigns were successful, they likely reduced mortality by mit-
igating epidemics. Since the nonmalarious regions effectively serve as controls
in the analysis, this would create a downward bias in the estimate of the impact
on malarious regions.
By far the biggest achievement of the program is the dramatic increase in
the use of ITNs. Reliable ownership and usage data are available from the
2003 DHS, the 2007 Kenya Malaria Indicator Survey, and the 2008–9 DHS.
Although ITN coverage was emphasized starting in 2001, survey evidence sug-
gests that ITN coverage and usage really took off between 2003 and 2006–7.
The proportion of households reporting ownership of at least one bed net
of any kind rose from 22% in 2003 to 63% in 2007 before falling slightly to
61% in 2008–9. The proportion of households with at least one ITN rose
from a mere 6% in 2003 to 48% in 2007 and 56% by 2008–9. The ITN cov-
erage for children under 5, deﬁned as the proportion of children under 5 who
slept under an ITN the night preceding the survey, rose from 5% in 2003 to
39% in 2007 and 46% by 2008–9. Table 2 presents the regional increase in
ITN ownership and usage between 2003 and 2008–9. In the highly malarious
Nyanza and Western regions, household ownership of ITNs rose from 11.3%
and 6.7% in 2003 to 76.5% and 71.4%, respectively, and the proportion ofThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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children under 5 who slept under bed nets rose from 7.4% and 4.8% to 60.9%
TABLE 2
REGIONAL CHANGES IN INSECTICIDE-TREATED BED NET ðITNÞ OWNERSHIP AND USAGE ð%Þ
ITN Ownership* ITN Usage ðunder 5Þy
2003 2008–9 D 2003 2008–9 D
Nonmalarious:
Central 3.4 32.7 29.3 3.9 35 31.1
Coast 10 66.3 56.3 7.5 56.9 49.4
Eastern 4.6 60.4 55.8 3.9 50.6 46.7
Nairobi 6.9 50.8 43.9 8.1 51.9 43.8
North Eastern 2.7 73.3 70.6 1.2 62.7 61.5
Rift Valley 3 41.4 38.4 2.5 29.5 27
Malarious:
Nyanza 11.3 76.5 65.2 7.4 60.9 53.5
Western 6.7 71.4 64.7 4.8 55.4 50.6
Sources. Kenya Demographic and Health Surveys 2003 and 2008–9.
* Households surveyed who owned an ITN.
y Households with children under 5 years of age who slept under an ITN the night before the survey.
Pathania 467and 55.4%, respectively, by 2008–9 ðCBS, MOH, and ORC Macro 2004;
KNBS and ICF Macro 2010Þ. In the nonmalarious regions, ITN coverage for
children under 5 also rose sharply, although the coverage achieved by 2008–9
was more varied, ranging from a low of 29.5% in the Rift Valley region to a high
of 62.7% in the North Eastern region. Accordingly, in the following analysis the
post intervention period is deﬁned as starting in 2004 onward.5
B. Effect on Mortality in Early versus Late Infancy
When analyzing the impact of improved malaria control on infant mortality,
it is useful to analyze separately the impact on early and late infancy because
the morbidity and mortality burden of malaria appears to vary substantially
between early infancy and the remainder of the ﬁrst year of life. Snow et al.
ð1998Þ conduct a prospective study of hospital admissions of African infants
across four sites with widely varying transmission intensity ðincluding three
sites in KenyaÞ. They ﬁnd evidence of signiﬁcant clinical protection against
severe malaria morbidity in the ﬁrst 3 months of infancy. This protection does
not appear to stem from a lower infection rate—neonates appear to get in-
fected at roughly similar rates as older infants ðKitua et al. 1996Þ. Instead
protection in the ﬁrst few weeks of life appears to be derived from Immu-
5 Given that the malaria strategy was put in place in 2001, and that ITN distribution commenced in
2002, it is conceivable that the campaign began to have an impact before 2004. Hence, as a robust-
ness check, I code 2001–3 as the buildup period, and 2004–8 as the post period, and track the rela-
tive changes in mortality in the malarious and nonmalarious regions in both those periods. As an ad-
ditional check presented in the online appendix, I test and ﬁnd that the estimates are robust to varying the
starting year of the post period.
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noglobulin G transferred through the placenta ðMcGregor 1986; Amaratunga
468 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Eet al. 2011Þ. This is consistent with several older studies that suggest signif-
icant clinical protection against malaria in early infancy—congenital malaria
is rare, and very young infants reportedly suffer only mild symptoms when
infected. Severe, life-threatening malaria in infancy usually occurs during the
latter part of the ﬁrst year of life ðGarnham 1949; Macdonald 1950; Col-
bourne and Edington 1954Þ. In line with standard practice in public health
and medical literature, I deﬁne neonatal ðﬁrst monthÞ and postneonatal ð1–
11 monthsÞ mortality indicators and analyze the impact of the campaign
on each separately.6 For the sake of completeness, I also present estimates of
the differential impact of the campaign on various phases of infancy, that is,
0 months ðneonatal as beforeÞ, 1–2, 3–5, and 6–11 months.
III. Data and Method
The mortality indicators are calculated from the 1998, 2003, and the 2008–9
Kenya Demographic and Health Surveys. These are nationally representative
surveys that collect detailed information on numerous population and health
characteristics. The primary respondents are women of reproductive age ð15–
49Þ. The women’s questionnaire covers topics such as socioeconomic char-
acteristics, complete reproductive history, antenatal and delivery care, immu-
nization of infants, infant and child care, and childhood mortality.
Using the birth history and reported age at death in the DHS, I construct
indicators of infant mortality ðdeath within the ﬁrst year of lifeÞ, neonatal mor-
tality ðwithin the ﬁrst monthÞ, and postneonatal ð1–11 monthsÞ for each live
birth in the sample.7 The postneonatal and infant mortality indicators are de-
ﬁned only for cohorts that were born at least 1 year before the survey date ðthese
6 Strictly speaking, neonatal mortality is deﬁned as death of a live-born infant within the ﬁrst 0–27
days of life. Postneonatal mortality is deﬁned as the death of a live-born infant during 28–364 days
of life. The two types of mortality are usually analyzed separately since most deaths occurring in the
neonatal period are driven by events surrounding the prenatal period and the delivery, while most
postneonatal deaths are associated with environmental factors that the infant is exposed to after de-
livery. See Rowley et al. ð1994Þ for a full discussion. In the context of this analysis, it is worth noting
that while the literature is not precise about the exact duration of protection, some of the studies
above suggest that maternally derived protection against severe malaria extends up to the ﬁrst 3
months of life. As a check, I have analyzed the impact on mortality in the 0–2- and 3–11-month age
brackets, and the point estimate for 0–2-month mortality is essentially zero, while that for 3–11-
month mortality is very close to that estimated for postneonatal mortality. Results are available from
the author on request.
7 The DHS contains information on the death of older children. I focus on infant mortality because
it accounts for the bulk of child mortality. Also, a birth-cohort-based measure of children-under-5
mortality would restrict me to cohorts born in 2003 and earlier since the most recent survey data
come from 2008 to 2009. However, I have analyzed children-under-5 mortality by counting the
This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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indicators are undeﬁned for infants who were alive and younger than 1 year at
Pathania 469the time of the surveyÞ. Hence, I restrict the sample to births that took place
at least 1 year before the survey date. Since the data related to birth history are
retrospective, recall bias is a concern, particularly for the more distant births. I
further restrict the analysis to recent births, occurring no earlier than 5 years of
the date of the interview. I am constrained to using at least 5 years as the cut-
off date for the following reason. If I set the cutoff at 4 years, then using the
2008–9 survey, I would be able to include births from 2004 to 2008 but not
2003. I cannot use data from the 2003 survey to construct postneonatal or in-
fant morality for the 2003 birth cohort since that cohort would have been too
young ði.e., less than 1 year old at the time of the surveyÞ. By setting the cutoff
at 5 years, I can use information in the 2003 and the 2008–9 DHS to include
births in 2003 and 1998, respectively. Accordingly, using the three surveys, I
can construct mortality indicators for infants born between 1993 and 2008.
The ﬁnal sample has 13,897 births.8 To mitigate any gender-speciﬁc recall bias,
I include gender-speciﬁc birth order as ﬁxed effects in all regressions.
The identiﬁcation strategy relies on preexisting variation across Kenya in
malaria risk. I estimate the following linear probability model for the mortality
among infants born between 1993 and 2008:
mijy 5 a1 gj 1 ry 1 b  posty malariaj 1 vXi 1 εijy; ð1Þ
where mijy is a mortality indicator for infant i born in region j in year y, and gj
and ry are region and year of birth ﬁxed effects respectively. The “malaria”
variable is the regional estimate of malaria risk as shown in table 1. The “post”
dummy denotes years starting in 2004. This is the intervention period that
witnessed a rapid intensiﬁcation of malaria control. The covariates Xi include
gender of the infant, maternal age, maternal education ðin completed yearsÞ,
number of household members, and indicators for multiple birth and place
of birth ðrural or urbanÞ. Also included are ﬁxed effects for religion and eth-
nicity of the head of the household, month of birth ðto capture any seasonal
variationÞ, birth order, and gender-speciﬁc birth order.9 The coefﬁcient of in-8 Even with a 5-year recall period, there remains a potential for bias due to selective migration of
mothers. In the online appendix, I test and ﬁnd that the estimates are robust to trimming the sample
to the subset of mothers who were resident in the region for at least 5 years or more.
9 The online appendix shows that the main ﬁndings are robust to the choice of both individual
child-level and household-level covariates.
deaths of children age 0–4 as a proportion of the stock of all children age 0–4 alive in the sample at
the start of the year. I ﬁnd a negative and signiﬁcant coefﬁcient ðthe same holds for mortality in the
1–4-years age groupÞ.
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terest is b, which measures the differential change in infant mortality in the
10
470 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Epost period for a unit rise in malaria risk.
Since the errors may be correlated with a region, I estimate cluster-robust
standard errors ðMoulton 1986, 1990Þ. However, the cluster-robust stand-
ard errors are asymptotically valid only if the number of clusters is large. With
a small number of clusters, the cluster-robust standard errors can be biased
downward. Since there are only eight clusters ðregionsÞ, I also calculate the
two-tailed p-values using the wild cluster bootstrap-Tmethod developed by
Cameron, Gelbach, and Miller ð2008Þ.
IV. Results
Before presenting the regression results, it is instructive to examine the sample
summary statistics in table 3. The table contains the mean and standard de-
viation of key variables for births in the pre and post periods by the level of
malaria risk. Speciﬁcally, the table contrasts the nonmalarious regions ðCen-
tral, Coastal, Eastern, Nairobi, North Eastern, and Rift ValleyÞ that have low
risk with the malarious regions ðNyanza andWesternÞ that have very high risk.
The reported p-values are from a test of difference in means between the ma-
larious and the nonmalarious regions. A higher fraction of births in malari-
ous regions occurs in rural areas and to slightly younger but more educated
mothers.11 The biggest difference between the malarious and the nonmalari-
ous regions is in infant mortality, particularly in the pre period.
Table 4 previews the major ﬁnding of this article. The table displays the
mean infant, neonatal, and postnatal mortality in the pre and post periods for
the nonmalarious and the malarious regions. Looking ﬁrst at the pre period,
one ﬁnds that infant mortality is much higher in the malarious regions. Al-
10 It is worth noting that the Nyanza and Western regions both have a similar level of very high
malaria risk, while four of the remaining six regions ðCentral, Eastern, Nairobi, and North EasternÞ
have close to zero risk. This suggests an alternative and equivalent approach: a textbook difference-in-
difference that would use a dummy to tag high malaria risk regions instead of a continuous regional
malaria rate variable. The zero-risk regions serve as a control allowing us to account for any secular
trends in infant mortality in Kenya. The virtue of this approach would be the ease of interpretation
of the relevant coefﬁcient—the prepost change in infant mortality in the high-risk regions relative
to the low-risk ones. The downside is that the Coastal and the Rift Valley regions that have small
pockets of high malaria risk and bigger pockets of moderate malaria risk would have to be excluded
from the analysis. For the sake of completeness, I opt for the estimation strategy in eq. ð1Þ. But I have
also estimated a standard difference-in-difference model in which I tag Nyanza and the Western re-
gions as malarious and all six other regions as nonmalarious. The results are essentially similar and
available in the online appendix.
11 The religious and ethnic composition of the sample is not reported in table 3 for the sake of
brevity. However, the regression analysis controls for differences in religious and ethnic composition
across regions.
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most all of that excess mortality occurs among postneonates—the neonatal
TABLE 3
SUMMARY STATISTICS FOR BIRTHS REPORTED IN KENYA DEMOGRAPHIC AND HEALTH SURVEYS
1998, 2003, AND 2008–9
Pre ð1993–2003Þ Post ð2004–8Þ
Nonmalarious* Malariousy p-Value Nonmalarious* Malariousy p-Value
Male .51 .50 .163 .51 .51 .642
ð.50Þ ð.50Þ ð.50Þ ð.50Þ
Multiple .03 .04 .091 .03 .04 .194
ð.17Þ ð.19Þ ð.17Þ ð.19Þ
Rural .77 .87 .000 .74 .82 .000
ð.42Þ ð.34Þ ð.44Þ ð.39Þ
Mother’s agez 26.34 25.97 .014 26.51 25.46 .000
ð6.51Þ ð6.61Þ ð6.60Þ ð6.45Þ
Mother’s education§ 6.26 6.90 .000 5.73 7.57 .000
ð4.18Þ ð3.28Þ ð4.69Þ ð2.87Þ
Household size 6.19 5.86 .000 5.83 6.01 .021
ð2.79Þ ð2.32Þ ð2.43Þ ð2.56Þ
Birth order 3.47 3.82 .000 3.44 3.49 .459
ð2.46Þ ð2.67Þ ð2.30Þ ð2.37Þ
Infant mortalityk 58.66 103.74 .000 46.02 64.84 .007
ð235.01Þ ð304.98Þ ð209.55Þ ð246.32Þ
Observations 6,465 2,698 3,238 1,496
Note. Mean values, with standard errors in parentheses. Only includes births within no earlier than 5 years
and no later than 1 year of the survey date. Reported p-values are for tests of difference in means between
the malarious and the nonmalarious regions. Summary statistics for distribution of births by tribe and re-
ligion are available from the author on request.
* Central, Coastal, Eastern, Nairobi, North Eastern, and Rift Valley provinces.
y Nyanza and Western provinces.
z In years, at time of infant’s birth.
§ In completed years, at time of survey.
k Per 1,000 live births.
Pathania 471mortality is similar in both types of regions. Next, looking at the post period,
one ﬁnds that infant mortality falls sharply in the malarious regions but de-
clines only modestly in the nonmalarious regions. Further, the relative fall in
infant mortality in the malarious regions is driven largely by a sharp reduction
in postneonatal mortality.
I now turn to estimating the regression models to assess the magnitude and
signiﬁcance of these differential changes in mortality. The regressions sample
includes live births from all eight regions. The results from estimating equa-
tion ð1Þ are presented in table 5. For the sake of brevity, only select controls
are reported.12
The regression results conﬁrm the basic ﬁnding reported in table 4. There is
a signiﬁcant fall in postneonatal mortality in the malarious regions relative to
12 The full set of results is available from the author on request.This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
All use subject to JSTOR Terms and Conditions
the nonmalarious regions in the post period. There is no such change for
TABLE 4
DIFFERENCE IN MEAN MORTALITY
Pre ð1993–2003Þ Post ð2004–8Þ D
Infant mortality:
Nonmalarious* 58.7 46.0 212.6
ð235.0Þ ð209.6Þ
Malariousy 103.7 64.8 238.9
ð305.0Þ ð246.3Þ 226.3
Neonatal mortality:
Nonmalarious* 33.3 29.6 23.7
ð179.5Þ ð169.6Þ
Malariousy 27.8 26.7 21.1
ð164.4Þ ð161.4Þ 2.6
Postneonatal mortality:
Nonmalarious* 25.3 16.4 28.9
ð157.1Þ ð126.9Þ
Malariousy 76.0 38.1 237.9
ð265.0Þ ð191.5Þ 228.9
Note. Mean values of mortality per 1,000 live births ðstandard errors in parenthesesÞ
for births within 1–5 years of the survey date.
* Central, Coastal, Eastern, Nairobi, North Eastern, and Rift Valley provinces.
y Nyanza and Western provinces.
472 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Eneonatal mortality; in fact the coefﬁcient on the post  malaria interaction is
positive albeit insigniﬁcant. The total change in infant mortality in the ma-
larious versus nonmalarious regions ðtable 5, col. 3Þ is accordingly smaller
than the relative fall in postneonatal mortality. The p-values from the wild
cluster bootstrap-T method are reported in square brackets for the coefﬁ-
cient of interest. The estimated impact on postneonatal mortality remains sig-
niﬁcant at 5%.
V. Robustness Checks
The excess postneonatal mortality in the high-risk regions preintervention is
consistent with malaria being a major source of infant mortality in the ma-
larious regions, particularly among postneonatal infants who have lost at least
some of the early infancy protection they originally enjoyed. Below, I further
explore the pattern of the relative fall in mortality over the course of infancy.
The sharper reduction in postneonatal mortality in the malarious regions post-
intervention suggests that intensiﬁed malaria control is having a substantial
impact. However, a skeptic may plausibly contend that the relative fall in post-
neonatal mortality in the malarious areas is not due to the intensiﬁcation of
malaria control but instead due to a relative improvement in other determinants
such as maternal and infant care or HIV/AIDS prevention and care or perhapsThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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preexisting differential trends; that is, mortality was already falling faster in the
TABLE 5
CHANGE IN INFANT, NEONATAL, AND POSTNEONATAL MORTALITY AND MALARIA PREVALENCE
0–11 months
ð1Þ
0 months
ð2Þ
1–11 months
ð3Þ
Post  malaria 2.00078 .00015 2.00094**
ð.00046Þ ð.00019Þ ð.00034Þ
½.332 ½.557 ½.041
Male .01450*** .00810** .00640*
ð.00342Þ ð.00261Þ ð.00321Þ
Multiple birth .15876*** .13614*** .02262**
ð.04271Þ ð.03823Þ ð.00942Þ
Rural 2.00007 .00145 2.00152
ð.00913Þ ð.00467Þ ð.00619Þ
Household sizea 2.00773*** 2.00328*** 2.00444*
ð.00192Þ ð.00049Þ ð.00200Þ
Mother’s ageb 2.00046 2.00004 2.00041
ð.00047Þ ð.00037Þ ð.00028Þ
Mother’s educationc 2.00318*** 2.00142** 2.00176***
ð.00053Þ ð.00043Þ ð.00049Þ
Constant .11882*** .06580*** .05302**
ð.02005Þ ð.01134Þ ð.01727Þ
R2 .04408 .03522 .03327
Note. Ordinary least squares regression coefﬁcients; other covariates include ﬁxed effects for birth order,
gender-speciﬁcbirthorder, religion, ethnicity ðtribeÞ,monthof birth, year of birth, and regionof birth. Robust
standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008, with
“post” deﬁned as years after 2003. Only includes births that took place within 1–5 years of the survey date.
“Malaria” is the regional Plasmodium falciparum parasite rate. Square brackets contain two-tailed p-values
for the post  malaria coefﬁcient based on the wild cluster bootstrap-Tmethod. N 5 13,897.
a At time of the survey.
b In years, at time of birth.
c In completed years, at time of survey.
* p < .1.
** p < .05.
*** p < .01.
Pathania 473malarious regions. I present results from a series of robustness checks that address
these possibilities.
A. Effect on Mortality in Early versus Late Infancy
To track the relative change in mortality over the course of infancy, I construct
mortality indicators for the following ages: 0 months ðneonatal as beforeÞ,
1–2, 3–5, and 6–11 months. For each of those indicators, I estimate equation
ð1Þ. The coefﬁcients on post  malaria are plotted in ﬁgure 4. It is evident
that the relative postintervention fall in mortality in the malarious regions is
entirely concentrated in the postneonatal period ð3–5 and 6–11 monthsÞ.
This differential pattern in the change in mortality over the course of the ﬁrst
year of life is strongly suggestive that it is improved malaria control that is
driving the reduction in mortality in the malarious regions.This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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B. Preexisting Trends in Malarious versus Nonmalarious Regions
Figure 4. Effect on mortality at different ages in infancy. Sample of births from 1993 to 2008; “post”
denotes years starting in 2004.
474 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G ECould preexisting trends be driving the observed drop in postneonatal mor-
tality in the malarious regions? To address this possibility, I include region-
speciﬁc time trends in equation ð1Þ so that the coefﬁcient on postmalaria is
now estimated from the variation around regional time trends. The results are
displayed in column 2 of table 6. To facilitate comparison, column 1 repro-
duces the results from table 5. The estimated impact on postneonatal mortal-
ity is robust to inclusion of regional trends. Note though that the estimate for
neonatal mortality becomes positive and signiﬁcant, suggesting that neonatal
mortality had been dropping in the malarious regions in the pre period but re-
versed course in the post period ðrelative to the nonmalarious regionsÞ. I also
check for possible mean reversion by including the average level of the depen-
dent variable for early birth cohorts in each region, interacted with the post
dummy. The results are displayed in table 6 column 3. The estimated impact
on postneonatal mortality remains negative and signiﬁcant, although its mag-
nitude is muted. However, this last result should be interpreted with some cau-
tion. If the high level of risk in the malarious regions was keeping postneo-
natal mortality artiﬁcially high in those regions, the post regional average term
could be soaking up some of the malaria effect that would mute the point es-
timate on postmalaria.This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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Finally, I use a more ﬂexible speciﬁcation that separately estimates the rel-
TABLE 6
PREEXISTING REGIONAL TRENDS IN MORTALITY
Baseline: Table 5
ð1Þ
Regional Trendsa
ð2Þ
Mean Reversion
ð3Þ
Dependent variable—infant mortality:
Post  malaria 2.00078 .00004 2.00008
ð.00046Þ ð.00021Þ ð.00025Þ
½.332 ½.759 ½.798
Post  regional average of dependent variableb 2.49298**
ð.19461Þ
R 2 .04408 .04677 .04495
Dependent variable—neonatal mortality:
Post  malaria .00015 .00070** .00021
ð.00019Þ ð.00021Þ ð.00020Þ
½.557 ½.080 ½.420
Post  regional average of dependent variableb 2.88321
ð.51164Þ
R 2 .03522 .03727 .03591
Dependent variable—postneonatal mortality:
Post  malaria 2.00094** 2.00066** 2.00031*
ð.00034Þ ð.00024Þ ð.00016Þ
½.041 ½.070 ½.212
Post  regional average of dependent variableb 2.46249***
ð.09446Þ
R 2 .03327 .03424 .03372
Note. Ordinary least squares regression coefﬁcients; covariates include gender, multiple birth indicator,
rural residence indicator, mother’s age, mother’s education, as well as ﬁxed effects for birth order, gender-
speciﬁc birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth. Robust
standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008, with
“post” deﬁned as years after 2003. Only includes births that took place within 1–5 years of the survey date.
“Malaria” is the regional Plasmodium falciparum parasite rate. Square brackets contain two-tailed p-values
for the post  malaria coefﬁcient based on the wild cluster bootstrap-T method. N 5 13,897.
a Regressions include a region-speciﬁc linear time trend.
b Mean reversion speciﬁcation includes an interaction of post with the regional average of the relevant
mortality measure for 1993–96.
* p < .1.
** p < .05.
*** p < .01.
Pathania 475ative change in infant mortality in the malarious regions during the campaign
buildup ð2002–3Þ and the post period ð2004–8Þ. The choice of 2004–8 as
postcampaign was motivated by the observation that ITN usage appeared to
take off after 2003. However, the National Malaria Strategy was adopted in
2001, and ITN distribution ðalthough only modestly subsidized and only
through the retail sectorÞ commenced in 2002. The results are displayed in
table 7. There appears to have been no change in postneonatal mortality dur-
ing the buildup, and the estimated impact during the post period remains es-
sentially unchanged.This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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C. Contemporaneous Programs
TABLE 7
CHANGE IN INFANT, NEONATAL, AND POSTNEONATAL MORTALITY DURING CAMPAIGN BUILDUP (2002–3)
AND THE POST PERIOD (2004–8)
0–11 months 0 months 1–11 months
Buildup  malariaa .00049 .00050 2.00000
ð.00105Þ ð.00054Þ ð.00055Þ
Post  malariaa 2.00074 .00020 2.00094**
ð.00042Þ ð.00021Þ ð.00030Þ
½.357 ½.388 ½.036
Male .01452*** .00811** .00640*
ð.00343Þ ð.00261Þ ð.00322Þ
Multiple birth .15848*** .13585*** .02262**
ð.04225Þ ð.03804Þ ð.00913Þ
Rural .00004 .00156 2.00152
ð.00928Þ ð.00473Þ ð.00627Þ
Household sizeb 2.00773*** 2.00329*** 2.00444*
ð.00192Þ ð.00049Þ ð.00200Þ
Mother’s agec 2.00046 2.00004 2.00041
ð.00047Þ ð.00037Þ ð.00028Þ
Mother’s educationd 2.00318*** 2.00142** 2.00176***
ð.00053Þ ð.00044Þ ð.00049Þ
Constant .11897*** .06595*** .05302**
ð.02007Þ ð.01138Þ ð.01728Þ
R 2 .04412 .03531 .03327
Note. Ordinary least squares regression coefﬁcients; other covariates include ﬁxed effects for birth order,
gender-speciﬁc birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth. Ro-
bust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008.
Only includes births that took place within 1–5 years of the survey date. “Malaria” is the regional Plasmo-
dium falciparum parasite rate. Square brackets contain two-tailed p-values for the post  malaria coefﬁcient
based on the wild cluster bootstrap-T method. N 5 13,897.
a Buildup is deﬁned as 2002–3, while post is deﬁned as 2004–8.
b At time of the survey.
c In years, at time of birth.
d In completed years, at time of survey.
* p < .1.
** p < .05.
*** p < .01.
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It is possible that the differential trends in mortality in the malarious regions
are being driven not by intensiﬁed malaria control but by relative improve-
ments in maternal and infant care in those regions. The DHS data contain
useful information on maternal and infant care indicators for births in the
5 years preceding the survey. Table 8 shows the estimates of differential changes
in various measures of antenatal care—one or more antenatal visits to health
facilities, receiving iron supplements and tetanus typhoid injections, and deliv-
ery at a health facility. There appears to be no relative change in the likelihood
of receiving antenatal care between the two types of regions—three of the four
coefﬁcients on post  malaria are small and statistically insigniﬁcant. If any-This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
All use subject to JSTOR Terms and Conditions
thing, antenatal care in the malarious regions may have worsened relative to the
TABLE 8
CONCURRENT CHANGES IN ANTENATAL CARE
Antenatal
Care?a
Iron
Supplement?
Tetanus
Injection?
Delivery at Health
Facility?b
Post  malaria 2.00069 2.00309 2.00064 2.00135*
ð.00086Þ ð.00171Þ ð.00083Þ ð.00060Þ
Male .00539 .00249 .00586 .01820
ð.00588Þ ð.00397Þ ð.01053Þ ð.01230Þ
Multiple birth .01231 2.04680 .05166*** .10166**
ð.02786Þ ð.03854Þ ð.01287Þ ð.03015Þ
Rural 2.03776 2.03115** 2.04471* 2.24491***
ð.02317Þ ð.01061Þ ð.02013Þ ð.02949Þ
Household sizec .00103 2.00388 .00037 2.00073
ð.00239Þ ð.00274Þ ð.00265Þ ð.00295Þ
Mother’s age .00022 .00116 .00055 .00989***
ð.00105Þ ð.00092Þ ð.00153Þ ð.00213Þ
Mother’s educationc .01031*** .01218** .00796** .03175***
ð.00085Þ ð.00351Þ ð.00283Þ ð.00243Þ
Constant .87294*** .66448*** .80367*** .37476**
ð.07378Þ ð.08070Þ ð.10331Þ ð.14061Þ
Observationsd 7,632 5,443 7,737 11,650
R 2 .18572 .12215 .13222 .28108
Note. Ordinary least squares regression coefﬁcients; other covariates include ﬁxed effects for birth order,
gender-speciﬁc birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth. Ro-
bust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008,
with “post” deﬁned as years after 2003. Only includes births that took place within 1–5 years of the sur-
vey date. “Malaria” is the regional Plasmodium falciparum parasite rate.
a Indicator for one or more antenatal visits to a health facility.
b Public or private health facility.
c At the time of the survey.
d Limited to births for which the dependent variable is recorded.
* p < .1.
** p < .05.
*** p < .01.
Pathania 477low-risk regions; the coefﬁcient for delivery at a health facility is negative and
marginally signiﬁcant.13
Table 9 shows the results of regressions estimating the relative changes in
immunization in the malarious versus nonmalarious regions. I investigate the
differential changes in the likelihood of receiving each of the several different
vaccines that constitute the immunization schedule in the ﬁrst year. Immu-
nization is a useful indicator of infant care not merely for any protection it
confers on the infant in the ﬁrst year of life but because it proxies for access to
and usage of health services. All the coefﬁcients on post  malaria are in-
13 The reader may notice that the sample size in table 8 varies across the columns and is in some cases
markedly less than the sample size in table 5. This is due to missing data for antenatal care indicators.
The key ﬁndings remain essentially unchanged if the mortality regressions are run only for the subset
of women for whom antenatal care data are available. These results are available on request.
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signiﬁcant. There is no evidence of any systematic changes in immunization
TABLE 9
CONCURRENT CHANGES IN IMMUNIZATION RATES
BCG Polio 1 Polio 2 Polio 3 DPT 1 DPT 2 DPT 3 Measles
Post  malaria 2.00139 2.00092 2.00048 .00021 2.00092 2.00049 .00015 .00044
ð.00149Þ ð.00097Þ ð.00120Þ ð.00110Þ ð.00139Þ ð.00145Þ ð.00094Þ ð.00115Þ
Male .00389 .00811 .00632 .01097 .00601 .00866 .00943 .01160
ð.00493Þ ð.00662Þ ð.00499Þ ð.00943Þ ð.00679Þ ð.00712Þ ð.00654Þ ð.00708Þ
Multiple birth 2.00157 2.00262 2.02249 .01356 2.00223 2.00130 .02031 .03697
ð.01849Þ ð.01556Þ ð.02217Þ ð.02798Þ ð.01875Þ ð.02726Þ ð.03939Þ ð.03637Þ
Rural 2.01802* .00863 .01880 .08015***2.01161 2.00449 .01555 2.03852*
ð.00780Þ ð.01094Þ ð.01340Þ ð.01525Þ ð.00702Þ ð.02238Þ ð.03290Þ ð.01878Þ
Household
sizea .00164 .00151** .00296** .00349*** .00071 .00331** .00581*** .00462***
ð.00122Þ ð.00061Þ ð.00093Þ ð.00082Þ ð.00112Þ ð.00119Þ ð.00153Þ ð.00096Þ
Mother’s age .00081 .00007 .00092 2.00005 .00006 .00045 .00135 .00329**
ð.00088Þ ð.00077Þ ð.00094Þ ð.00137Þ ð.00071Þ ð.00065Þ ð.00124Þ ð.00127Þ
Mother’s
educationa .00574*** .00513*** .00857*** .00742*** .00597*** .00973***.01261*** .01323***
ð.00101Þ ð.00072Þ ð.00143Þ ð.00183Þ ð.00095Þ ð.00150Þ ð.00196Þ ð.00182Þ
Constant .86804*** .89370*** .84673*** .46765*** .88906*** .78032***.62753*** .82301***
ð.06430Þ ð.04133Þ ð.06077Þ ð.09648Þ ð.05019Þ ð.08657Þ ð.14440Þ ð.07601Þ
Observationsb 10,782 10,798 10,795 10,795 10,782 10,778 10,778 10,770
R 2 .13007 .10031 .11195 .08290 .13654 .14412 .14023 .11232
Note. Ordinary least squares regression coefﬁcients; regressions include ﬁxed effects for birth order,
gender-speciﬁc birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth.
Robust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to
2008, with “post” deﬁned as years after 2003. Only includes births that took place within 1–5 years of the
survey date. “Malaria” is the regional Plasmodium falciparum parasite rate. Immunization schedule for
Kenya: BCG ðBacille Calmette-GuérinÞ is given at birth; the oral polio vaccine is given at birth, 6 weeks,
and 10 weeks, respectively; DPT (diphtheria, pertussis, and tetanus) 1, 2, and 3 are given at 6, 10, and
14 weeks, respectively; and measles is given at 9 months.
a At the time of the survey.
b Limited to births for which the dependent variable is recorded.
* p < .1.
** p < .05.
*** p < .01.
478 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Ebetween malarious and nonmalarious regions; in particular the malarious re-
gions are not doing any better in the post period.
2. HIV/AIDS
While malaria has traditionally been a major cause of infant mortality in
Africa, HIV has recently emerged as another big contributor ðNewell et al.
2004Þ. HIV prevalence in Kenya overlaps to some degree with malaria risk;
for example, the Nyanza region, which has high malaria risk, also has the high-
est HIV prevalence. The Global Fund, which has provided much of the ﬁ-
nancial support for intensiﬁed malaria control in the post period, also funded
a major concurrent expansion of HIV prevention and treatment. Early retrovi-
ral therapy has been shown to reduce mortality among infected infants by aboutThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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75% ðViolari et al. 2008Þ. Could some or most of the differential fall in mor-
TABLE 10
CHANGES IN INFANT, NEONATAL, AND POSTNEONATAL MORTALITY AND MALARIA AND HIV PREVALENCE
0–11 months 0 months 1–11 months
Post  malaria 2.00054 .00016 2.00070**
ð.00043Þ ð.00024Þ ð.00023Þ
½.325 ½.618 ½.086
Post  HIV 2.00156 2.00001 2.00156
ð.00146Þ ð.00066Þ ð.00092Þ
Male .01437*** .00805** .00632*
ð.00338Þ ð.00258Þ ð.00321Þ
Multiple .15897*** .13622*** .02275**
ð.04263Þ ð.03818Þ ð.00933Þ
Rural 2.00030 .00135 2.00166
ð.00917Þ ð.00466Þ ð.00624Þ
Household sizea 2.00773*** 2.00327*** 2.00445*
ð.00193Þ ð.00049Þ ð.00201Þ
Mother’s ageb 2.00046 2.00004 2.00042
ð.00047Þ ð.00037Þ ð.00028Þ
Mother’s educationa 2.00316*** 2.00143** 2.00173***
ð.00051Þ ð.00043Þ ð.00048Þ
Constant .12198*** .06623*** .05575**
ð.02129Þ ð.01209Þ ð.01801Þ
R 2 .04431 .03548 .03331
Note. Ordinary least squares regression coefﬁcients; other covariates include ﬁxed effects for birth or-
der, gender-speciﬁc birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth.
Robust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to
2008, with “post” deﬁned as years after 2003. Only includes births that took place within 1–5 years of the
survey date. “Malaria” is the regional Plasmodium falciparum parasite rate, while “HIV” is the regional HIV
prevalence among women age 15–49. Square brackets contain two-tailed p-values for the post  malaria
coefﬁcient based on the wild cluster bootstrap-T method. N 5 13,897.
a At the time of the survey.
b In years, at the time of birth.
* p < .1.
** p < .05.
*** p < .01.
Pathania 479tality be due to a reduction in HIV burden? Montana, Neuman, and Mishra
ð2007Þ use the 2003 Kenya DHS to estimate the regional HIV prevalence rates
in Kenya for women age 15–49, which are displayed in the ﬁnal column of
table 1. I reestimate equation ð1Þ but include postHIVon the right-hand side
as an additional control. The coefﬁcient on post  malaria now represents the
postintervention change in mortality in the malarious regions after controlling
for any concurrent impact of the HIV/AIDS program. The results are pre-
sented in table 10. The coefﬁcient on post  HIV is negative but insigniﬁcant.
There is a modest fall in the magnitude of the coefﬁcient on postmalaria, but
it remains highly signiﬁcant for postneonatal mortality.14
14 Caution should be exercised comparing the magnitudes of the coefﬁcients on post  malaria and
post  HIV. The coefﬁcients represent the prepost change in mortality per unit of prevalence of ma-
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480 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G EIt is useful to interpret the reported estimates in terms of a more conventional
mortality metric ði.e., a rate per 1,000 live birthsÞ. To remain conservative, I
choose the coefﬁcient of 2.00066 reported in table 6 for the speciﬁcation
that controls for regional time trends. This estimate maps to a fall in post-
neonatal mortality of about 25 per 1,000 in the malarious Western region.15
The mean postneonatal mortality rate in the malarious regions in the pre-
period was 76 per 1,000 ðsee the bottom panel in table 4Þ. Thus, the estimate
implies that the malaria control campaign led to a fall of about 33% in the
mean postneonatal mortality rate in the Western region.
This is likely an underestimate of the true impact of the campaign in the
malarious reasons. The reason is that while I use the change in nonmalarious
regions to control for any secular trend in infant mortality across Kenya, those
“control” regions were also targeted by the campaign. For instance, there had
been a large jump in ITN usage in the nonmalarious regions. And, the IRS
has been focused on the epidemic-prone parts of those regions. These cam-
paign activities are likely to have reduced malaria-related mortality in the non-
malarious regions as well. Intuitively, using the relative change in mortality in
the malarious regions underestimates the true impact of the campaign in those
regions because we are netting out the drop in malaria-related mortality in
the nonmalarious regions due to the campaign.16
Using a back-of-the-envelope calculation, I map this ﬁnding to an estimate
of infant lives saved in the highly malarious regions. Nyanza and the Western
regions have a population of about 5.4 and 4.3 million respectively.17 The
birth rate in Kenya is about 3.84 per 100.18 The point estimate of 20.00066
ðafter controlling for regional time trendsÞ maps to relative drops in post-
neonatal mortality of about 22 and 25 per 1,000, respectively. That implies
on average 4,561 and 4,128 infants saved annually in Nyanza and theWestern
regions, respectively, during 2004–8, or a total of 43,445 infants over the 5-
year period.
Measuring the impact purely in terms of deaths averted understates the ben-
eﬁts of malaria control. Malaria is a major cause of morbidity during pregnancy
laria and HIV, respectively. The regional prevalence of malaria is much higher and very different from15 The difference in the Pf PR rates between the Western region and Nairobi is 38.84 2 0.05 ≈ 38.
Multiplying by the estimated effect of 2.00066 and scaling to 1,000 births yields about 25.
16 I thank a perceptive referee for drawing attention to this point.
17 Table 4 of Noor et al. ð2009Þ.
18 In 2009, the population of Kenya was 39.8 million and the annual number of births was 1.53 mil-
lion, which yields a birth rate of 3.84 per 100 ðhttp://www.unicef.org/infobycountry/kenya_statistics
.htmlÞ.
that of HIV.
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and early life, and there is a growing body of evidence that in utero and early life
Pathania 481exposure to adverse health shocks leave a lasting imprint. Almond ð2006Þ ﬁnds
that in utero exposure to the 1918 inﬂuenza epidemic lowered adult income
and schooling for the affected cohorts. Almond and Mazumder ð2011Þ show
that in utero exposure to maternal fasting during Ramadan leads to learning
disabilities and adverse effects on schooling and income. Barreca ð2010Þ ﬁnds
that cohorts born in the warmer and wetter months in the early part of the
twentieth century in the southern part of the United States have less edu-
cation; he attributes this to the higher burden of malaria in those months.
Bleakley ð2010aÞ provides a recent review of this literature including several
studies showing that childhood morbidity due to infection by tropical para-
sites can permanently scar human capital and reduce income.
Some of these studies explore the long-run impact of malaria eradication
campaigns. Just as in this article, the recent studies exploit the quasi-experimental
nature of the campaigns: identiﬁcation stems from preexisting variation in the
burden of malaria due to climatic and geographical differences combined with
the large and sudden changes in the disease burden due to the campaigns that
led to plausibly exogenous spatial and time variation in malaria exposure across
birth cohorts. Cutler et al. ð2010Þ ﬁnd gains in household consumption for
cohorts of adult men born in regions of high malaria prevalence during In-
dia’s malaria eradication campaign of 1950s. Lucas ð2010Þ looks at the impact
of malaria eradication campaigns in Paraguay and Sri Lanka and concludes
that reducing malaria incidence by 10 percentage points increases completed
years of schooling by 0.1 years and the probability of being literate by 1 per-
centage point. Bleakley ð2010bÞ ﬁnds that malaria eradication campaigns of
the United States ðca. 1920Þ and Brazil, Columbia, andMexico ðca. 1955Þ led
to higher income and literacy rates among cohorts born in areas with high
malaria prevalence ðrelative to cohorts born in areas with low prevalenceÞ. He
concludes that being infected with malaria through childhood leads to a re-
duction in adult income of about 50%. Since the estimates are at the cohort
level, any selection and general equilibrium effects are already embedded in
that estimate.
VII. Evidence from Other Studies
The ﬁndings are consistent with an older and related literature on the efﬁcacy
of bed nets. This includes several individual and clustered randomized control
trials. Lengeler ð2004Þ provides a comprehensive review. The trials ﬁnd that,
in areas of stable malaria, ITNs reduce the incidence of severe malaria by
about 45%. Other studies have found a signiﬁcant impact on child mortality
of past malaria control campaigns. Payne et al. ð1976Þ and Bradley ð1991ÞThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
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found that the insecticide-spraying campaigns in Kenya, Nigeria, and Tan-
482 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Ezania in the 1950s and 1970s reduced mortality among infants and children
age 1–4 years by as much as 40%–50%. Alonso et al. ð1991Þ report that ma-
laria chemoprophylaxis and ITNs reduced children-under-5 mortality by 42%
in Gambia. The magnitude of these ﬁndings is in line with the 33% drop cal-
culated above.
Of direct relevance are the newer studies of the impact of the recent in-
tensiﬁcation of malaria control. These studies are typically before-after com-
parisons using admissions and outcomes data from health facilities; some have
a difference-in-difference ﬂavor in that nonmalaria cases and deaths are used
as controls. Otten et al. ð2009Þ have investigated the impact of the recent and
rapid intensiﬁcation of malaria control in Rwanda and Ethiopia by tracking
inpatient malaria cases and mortality among children under 5 in select sites
before ð2001–6Þ and after ð2007Þ nationwide implementation of long-lasting
insecticide nets and artemisinin-based combination therapy. They ﬁnd that
malaria cases and deaths fall by 73% and 62%, respectively, in Ethiopia and
by 55% and 67%, respectively, in Rwanda. In contrast, they ﬁnd that non-
malaria cases and deaths remain stable or increase. Similarly, Aregawi et al.
ð2011Þ ﬁnd that the rapid scale-up of malaria control in Zanzibar has reduced
malaria deaths and inpatient and outpatient cases at health facilities in Zan-
zibar by 90%, 78%, and 99.5%, respectively, by 2008 ðas compared to the
preintervention period 1999–2003Þ. Studies of malaria admission rates from
coastal Kenya report dramatic falls of up to 90% in some hospitals in recent
years ðOkiro et al. 2007; O’Meara et al. 2008; Snow and Marsh 2010Þ. While
such studies are useful in ﬂagging trends, it is difﬁcult to use the ﬁndings to
construct an accurate national picture of the true impact of malaria control
because of poor record keeping and poor coverage of health facilities in de-
veloping countries.
Demombynes and Trommlerová ð2012Þ have used DHS data from Kenya
to investigate the recent decline in infant mortality. They also ﬁnd a sharp
fall in postneonatal mortality. They use an Oaxaca-Blinder decomposition to
conclude that the use of ITNs in malaria endemic areas explains about 39%
of the decline in postneonatal mortality. In contrast, I ﬁnd that the malaria
campaign led to a decline of 58% and 65% in postneonatal mortality in the
malarious Nyanza and Western regions, respectively.19
However, in another recent study, Tarozzi et al. ð2011Þ report an unusual
ﬁnding. They detect no health improvements from increased ownership and
19 The relative drops of 22 and 25 per 1,000 in Nyanza and the Western regions as fractions of the
overall drop of 38 per 1,000 in postneonatal mortality ðsee table 4Þ.
This content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
All use subject to JSTOR Terms and Conditions
usage of ITNs in a large-scale cluster randomized controlled trial in rural
Pathania 483Orissa ðIndiaÞ. They discuss at length various possible explanations to rec-
oncile their ﬁndings with those of several earlier trials that found large re-
ductions in malaria burden after the distribution of ITNs. They conclude that
the most plausible explanation is the relatively low coverage of ITNs and no
monitoring of usage in their study. Their trial did not achieve more than 50%
coverage in any study village, with the typical coverage rate being signiﬁcantly
less than 50%. Hence, the increase in ITN ownership and usage within study
villages was insufﬁcient to break the cycle of malaria transmission. In contrast,
most clinical trials have high coverage and close monitoring of usage. These
ﬁndings raise a question about the true efﬁcacy of ITNs in real-world settings
where coverage may be low and usage is not monitored.
How does one reconcile the ﬁndings of Tarozzi et al. ð2011Þ with the ﬁnd-
ings in the current study? One possible explanation is the higher ownership
and usage of ITNs in Kenya; the ownership in the highly malarious Nyanza
region had risen to about 75% by 2008–9, and about 60% of children under
5 years of age were sleeping under ITNs ðKNBS and ICF Macro 2010Þ. Stud-
ies have documented the existence of substantial nonlinearity in the relation-
ship between coverage and health beneﬁts from ITNs ðGimnig et al. 2003;
Hawley et al. 2003Þ. Another reason could be the difference in settings and the
species of the parasite—Plasmodium falciparum in sub-Saharan Africa versus
Plasmodium vivax in India—although this remains speculative in the absence
of further research. It is instructive to examine the ﬁndings of a study from at
least one other African setting with comparable ITN coverage ðchildren sleep-
ing under bed netsÞ of about 60%. D’alessandro et al. ð1995Þ conducted a clus-
ter randomized trial of ITN efﬁcacy in villages in ﬁve areas of Gambia. Trained
health workers impregnated bed nets with insecticide in treatment villages. The
researchers estimated that about 60% of children slept under ITNs in the
treated villages. Treated and control villages had similar postneonatal mortality
before the intervention. After the intervention, postneonatal mortality was 43
per 1,000 in the control villages but only 31 per 1,000 in the treated villages—a
drop of about 28%. They also found a drop of 25% in all-cause mortality of
older children age 1–9 years, a ﬁnding in line with the estimate of the current
analysis.
VIII. Conclusion
Kenya has witnessed a major campaign against malaria since the adoption of
the National Malaria Strategy in 2001. Funding for the malaria program has
risen several fold. The strategy emphasized the use of ITNs, and its biggest
achievement had been a large increase in ITN coverage since 2003. Data fromThis content downloaded from 139.184.30.133 on Mon, 14 Jul 2014 09:58:06 AM
All use subject to JSTOR Terms and Conditions
health facilities point to a major drop in the burden of malaria. However, it is
484 E C O N O M I C D E V E L O P M E N T A N D C U L T U R A L C H A N G Echallenging to construct a representative national picture on the basis of such
data due to poor formal health system coverage. I use large preexisting dif-
ferences in the regional risk of malaria coupled with the sharp timing of the
renewed campaign to study the impact on infant mortality. I ﬁnd that before
the intervention, infant mortality in the malarious regions was substantially
higher than that in the nonmalarious regions. Much of that difference was
due to higher postneonatal mortality in the malarious regions, consistent with
a key stylized fact from malaria epidemiology: malaria is most deleterious in
later infancy with very young infants enjoying maternally conferred protec-
tion. Postintervention, I ﬁnd a signiﬁcant fall in postneonatal mortality in the
malarious regions vis-à-vis the nonmalarious regions. There is no such relative
fall in neonatal mortality. Robustness checks show that the sharp reduction in
postneonatal mortality in the malarious regions cannot be explained by pre-
existing trends. Neither can it be explained by differential changes in maternal
and infant care across the two types of regions. Further, the ﬁndings are robust
to any potential impact on infant mortality of the contemporaneous expan-
sion of HIV/AIDS prevention and treatment.
The preferred speciﬁcation suggests that the renewed malaria campaign led
to a fall in postneonatal mortality of 22–25 per 1,000 live births in the malar-
ious regions. This amounts to a drop of 33% in postneonatal mortality, which
maps to an estimated 43,445 infant lives saved in those regions during 2004–8.
While clinical trials have already demonstrated the efﬁcacy of ITNs, the ﬁnd-
ings here suggest large health beneﬁts from the use of ITNs during routine
program implementation where coverage is lower and usage is not closely mon-
itored. The ﬁndings in this article support the case for sustaining the mo-
mentum of the current campaign against malaria.
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